SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
科研木头人
Lv6
1930 积分
2023-08-01 加入
最近求助
最近应助
互助留言
Antibody–drug conjugates come of age in oncology
5天前
已完结
A Review of the Current FDA-Approved Antibody-Drug Conjugates: Landmark Clinical Trials and Indications
5天前
已完结
Exploring the next generation of antibody–drug conjugates
5天前
已完结
Identification of STX-721, an EGFR exon 20 mutant inhibitor with superior selectivity and a potential best-in-class profile
1个月前
已完结
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer
1个月前
已完结
Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment
1个月前
已完结
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
1个月前
已完结
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS)
1个月前
已关闭
Targeted Approaches to Treatment of Pleural Mesothelioma: A Review
1个月前
已完结
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
1个月前
已完结
没有进行任何应助
未及时上传【积分已退回】
1个月前
缺页,没有图
1个月前
NO NEED【积分已退回】
3个月前
太慢了【积分已退回】
7个月前
不需要了【积分已退回】
8个月前
感谢
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论